Correlation Between ProPhase Labs and OncoCyte Corp

Can any of the company-specific risk be diversified away by investing in both ProPhase Labs and OncoCyte Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProPhase Labs and OncoCyte Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ProPhase Labs and OncoCyte Corp, you can compare the effects of market volatilities on ProPhase Labs and OncoCyte Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProPhase Labs with a short position of OncoCyte Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProPhase Labs and OncoCyte Corp.

Diversification Opportunities for ProPhase Labs and OncoCyte Corp

0.83

Correlation Coefficient

ProPhase Labs  OncoCyte Corp

Very poor diversification

The 3 months correlation between ProPhase and OncoCyte is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding ProPhase Labs and OncoCyte Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoCyte Corp and ProPhase Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProPhase Labs are associated (or correlated) with OncoCyte Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoCyte Corp has no effect on the direction of ProPhase Labs i.e., ProPhase Labs and OncoCyte Corp go up and down completely randomly.

Pair Corralation between ProPhase Labs and OncoCyte Corp

Given the investment horizon of 90 days ProPhase Labs is expected to under-perform the OncoCyte Corp. In addition to that, ProPhase Labs is 2.5 times more volatile than OncoCyte Corp. It trades about -0.19 of its total potential returns per unit of risk. OncoCyte Corp is currently generating about -0.11 per unit of volatility. If you would invest  305.00  in OncoCyte Corp on September 5, 2024 and sell it today you would lose (65.00) from holding OncoCyte Corp or give up 21.31% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

ProPhase Labs  vs.  OncoCyte Corp

ProPhase Labs

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ProPhase Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

OncoCyte Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days OncoCyte Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with ProPhase Labs and OncoCyte Corp

The main advantage of trading using opposite ProPhase Labs and OncoCyte Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProPhase Labs position performs unexpectedly, OncoCyte Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoCyte Corp will offset losses from the drop in OncoCyte Corp's long position.

The idea behind ProPhase Labs and OncoCyte Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.